• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东和非洲斑秃综述:现状与未满足的需求

Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs.

作者信息

Al Hammadi Anwar, Parmar Nisha V, Aljefri Khadija, Al Sharif Osama, Abdallah Marwa, Ahmed Haytham Mohamed, Ammoury Alfred

机构信息

Department of Dermatology, Dermamed Clinic, Dubai, UAE.

Department of Dermatology, Rashid Hospital, Dubai Health Authority, Dubai, UAE.

出版信息

Dermatol Ther (Heidelb). 2023 Jul;13(7):1435-1464. doi: 10.1007/s13555-023-00946-8. Epub 2023 Jun 20.

DOI:10.1007/s13555-023-00946-8
PMID:37338721
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10307736/
Abstract

BACKGROUND

Alopecia areata (AA) is an autoimmune disease characterized by non-scarring hair loss in adults and children. Clinical manifestations range from hair loss in small, well-circumscribed patches to total hair loss on the scalp or any other hair-bearing areas. Although the exact pathogenesis of AA is not fully understood, it is thought that loss of immune privilege caused by immunological dysregulation of the hair follicle is key. Genetic susceptibility also plays a role. Response to currently available treatments is widely variable, causing patient dissatisfaction and creating an unmet need. AA is frequently associated with multiple comorbidities, further affecting patient quality of life.

AIMS AND FINDINGS

AA causes a significant burden on dermatologists and healthcare systems in the Middle East and Africa. There is a lack of data registries, local consensus, and treatment guidelines in the region. Limited public awareness, availability of treatments, and patient support need to be addressed to improve disease management in the region. A literature review was conducted to identify relevant publications and highlight regional data on prevalence rates, diagnosis, quality of life, treatment modalities, and unmet needs for AA in the Middle East and Africa.

摘要

背景

斑秃(AA)是一种自身免疫性疾病,其特征为成人和儿童出现非瘢痕性脱发。临床表现范围从边界清晰的小片状脱发到头皮或任何其他有毛发区域的全秃。尽管AA的确切发病机制尚未完全明确,但人们认为毛囊免疫调节异常导致的免疫豁免丧失是关键因素。遗传易感性也起作用。对现有治疗方法的反应差异很大,导致患者不满,存在未满足的需求。AA常与多种合并症相关,进一步影响患者生活质量。

目的与发现

AA给中东和非洲的皮肤科医生及医疗系统带来了沉重负担。该地区缺乏数据登记、当地共识和治疗指南。需要解决公众意识有限、治疗可及性以及患者支持等问题,以改善该地区的疾病管理。进行了一项文献综述,以识别相关出版物,并突出中东和非洲地区关于AA患病率、诊断、生活质量、治疗方式及未满足需求的区域数据。

相似文献

1
Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs.中东和非洲斑秃综述:现状与未满足的需求
Dermatol Ther (Heidelb). 2023 Jul;13(7):1435-1464. doi: 10.1007/s13555-023-00946-8. Epub 2023 Jun 20.
2
Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician's Survey in the Middle East.斑秃治疗模式与未满足需求:中东地区医生调查结果
Dermatol Ther (Heidelb). 2023 Aug;13(8):1801-1815. doi: 10.1007/s13555-023-00963-7. Epub 2023 Jun 24.
3
Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey.患者报告的重度斑秃负担:多国斑秃未满足需求调查的初步结果
Clin Cosmet Investig Dermatol. 2024 Mar 29;17:751-761. doi: 10.2147/CCID.S445646. eCollection 2024.
4
Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan.日本皮肤科医生和患者对斑秃治疗成功率的看法及临床疗效评估
Dermatol Ther (Heidelb). 2021 Apr;11(2):433-447. doi: 10.1007/s13555-020-00477-6. Epub 2021 Jan 10.
5
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.斑秃:发病机制、诊断和治疗的最新进展。
Clin Rev Allergy Immunol. 2021 Dec;61(3):403-423. doi: 10.1007/s12016-021-08883-0. Epub 2021 Aug 17.
6
Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.儿童斑秃:治疗概述及近期专利。
Recent Pat Inflamm Allergy Drug Discov. 2020;14(2):117-132. doi: 10.2174/1872213X14999200728145822.
7
Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system.治疗斑秃的新药发现的创新策略:针对免疫系统。
Expert Opin Drug Discov. 2024 Nov;19(11):1321-1338. doi: 10.1080/17460441.2024.2409660. Epub 2024 Oct 3.
8
Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.斑秃:疾病特征、临床评估及发病机制的新观点。
J Am Acad Dermatol. 2018 Jan;78(1):1-12. doi: 10.1016/j.jaad.2017.04.1141.
9
Alopecia Areata: A Review of the Genetic Variants and Immunodeficiency Disorders Associated with Alopecia Areata.斑秃:与斑秃相关的基因变异和免疫缺陷疾病综述
Skin Appendage Disord. 2023 Oct;9(5):325-332. doi: 10.1159/000530432. Epub 2023 Jul 4.
10
The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata.斑秃患者报告的脱发严重程度与健康相关生活质量及治疗模式之间的关系
Dermatol Ther (Heidelb). 2022 Apr;12(4):989-997. doi: 10.1007/s13555-022-00702-4. Epub 2022 Mar 29.

引用本文的文献

1
Alopecia: A Google Trends Analysis of the Past 5 Years (2018-2023).脱发:过去五年(2018 - 2023年)的谷歌趋势分析
Skin Appendage Disord. 2025 Jun;11(3):282-286. doi: 10.1159/000541548. Epub 2024 Nov 1.

本文引用的文献

1
Healthcare system development in the Middle East and North Africa region: Challenges, endeavors and prospective opportunities.中东和北非地区的医疗体系发展:挑战、努力与未来机遇。
Front Public Health. 2022 Dec 22;10:1045739. doi: 10.3389/fpubh.2022.1045739. eCollection 2022.
2
Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels.斑秃在全球、区域和国家各级的流行病学趋势。
Front Immunol. 2022 Jul 14;13:874677. doi: 10.3389/fimmu.2022.874677. eCollection 2022.
3
Two Phase 3 Trials of Baricitinib for Alopecia Areata.两项关于巴瑞替尼治疗斑秃的3期试验。
N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26.
4
Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population.斑秃与托法替布:一项来自沙特人群的前瞻性多中心研究。
Int J Dermatol. 2022 Jul;61(7):886-894. doi: 10.1111/ijd.15917. Epub 2021 Oct 29.
5
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.用于临床的斑秃量表的开发:一项学术-产业合作成果
J Am Acad Dermatol. 2022 Feb;86(2):359-364. doi: 10.1016/j.jaad.2021.08.043. Epub 2021 Aug 30.
6
Is the severity of initial sensitization to diphenylcyclopropenone in alopecia areata patients predictive of the final clinical response?斑秃患者初次致敏二苯环丙烯酮的严重程度是否可预测最终的临床反应?
Dermatol Ther. 2021 Nov;34(6):e15118. doi: 10.1111/dth.15118. Epub 2021 Sep 12.
7
Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-blind, Placebo-controlled, Clinical Trial.口服脉冲倍他米松、甲氨蝶呤及联合疗法治疗重度斑秃:一项随机、双盲、安慰剂对照临床试验
Iran J Pharm Res. 2021 Winter;20(1):267-273. doi: 10.22037/ijpr.2020.113868.14536.
8
A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.一项比较二苯环丙烯酮(DPCP)联合蒽林与 DPCP 单药治疗中重度斑秃的随机试验。
Int Immunopharmacol. 2021 Oct;99:107971. doi: 10.1016/j.intimp.2021.107971. Epub 2021 Jul 20.
9
Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata.评价斑秃患者血清白细胞介素(IL-2、IL-4、IL-15 和 IL-17)水平及其与疾病严重程度的关系。
An Bras Dermatol. 2021 Sep-Oct;96(5):551-557. doi: 10.1016/j.abd.2021.03.006. Epub 2021 Jul 17.
10
Association Between Vitamin D and Zinc Levels With Alopecia Areata Phenotypes at a Tertiary Care Center.三级护理中心维生素D和锌水平与斑秃表型之间的关联
Cureus. 2021 Apr 28;13(4):e14738. doi: 10.7759/cureus.14738.